SCT-I10A Plus SCT510 Versus Sorafenib as First-Line Therapy for Advanced Hepatocellular Carcinoma
Clinical trial NCT04560894 · UNKNOWN
Trial details
- NCT number
- NCT04560894
- Sponsor
- Sinocelltech Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-11
- Primary completion
- 2024-04-01
- Enrollment
- 405
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.